A&J Science, an innovative biotech company based in South Korea and dedicated to addressing AMR, is advancing two distinct pre-clinical candidates for C. difficile infection (CDI) and non-tuberculous mycobacterial pulmonary disease (NTM-PD) indications into IND-enabling [...]
More news
Do you have an outstanding antimicrobial resistance (AMR) innovation that you would like to share [...]
After receiving over 40 applications and going through a rigorous decision process, the finalists for [...]
As December arrives and 2023 draws to a close, it's time for reflection. The statistics [...]
December 6th 2023 – INCATE (the INCubator for Antibacterial Therapies in Europe) and Kineticos AMR [...]
The INCATE Selection Committee selected the last 4 new ventures for Stage I support in [...]
On November 8th 2023 we organized INCATEs 3rd Entrepreneurs Club about ways to get funding [...]
Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined forces to create PACE (Pathways [...]
November 1st, 2023 - INCATE (the INCubator for Antibacterial Therapies in Europe) and BIOASTER, the [...]
